News: E I du Pont de Nemours and Co (DD)

DD on New York Consolidated

75.36USD
28 Apr 2015
Change (% chg)

$0.55 (+0.74%)
Prev Close
$74.81
Open
$75.36
Day's High
$75.80
Day's Low
$74.78
Volume
3,941,239
Avg. Vol
5,172,600
52-wk High
$80.65
52-wk Low
$63.70

Search Stocks
Select another date:

Mon, Apr 27 2015

Photo

DuPont open to last-minute settlement talks with activist: sources

NEW YORK - DuPont's board is open to a negotiated settlement with activist Trian Fund Management in the run-up to the company's annual shareholder meeting in May, sources close to the matter said on Monday.

DuPont open to last-minute settlement talks with activist-sources

NEW YORK, April 27 - DuPont's board is open to a negotiated settlement with activist Trian Fund Management in the run-up to the company's annual shareholder meeting in May, sources close to the matter said on Monday.

REFILE-UPDATE 3-ISS backs Nelson Peltz's demand for DuPont board seat

April 27 - U.S. proxy advisory firm ISS recommended that DuPont shareholders vote in favor of Nelson Peltz joining the company's board, a shot in the arm for the activist investor ahead of voting on May 13.

ISS backs Nelson Peltz' demand for DuPont board seat-WSJ

April 27 - U.S. proxy advisory firm ISS has recommended DuPont shareholders vote in favor of activist investor Nelson Peltz and another nominee joining the chemical conglomerate's board, the Wall Street Journal reported.

Deals of the day- Mergers and acquisitions

April 22 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

DuPont buying microbiome firm, seeks edge in emerging crop products

- DuPont is buying a California-based microbiome discovery company for development of biological crop products, a move that the chemical and crop company hopes will give it an edge in an emerging agricultural market.

UPDATE 1-DuPont buying microbiome firm, seeks edge in emerging crop products

April 22 - DuPont is buying a California-based microbiome discovery company for development of biological crop products, a move that the chemical and crop company hopes will give it an edge in an emerging agricultural market.

DuPont buys microbiome firm, seeks edge in emerging crop products

April 22 - DuPont is buying a California-based microbiome discovery company for development of biological crop products, a move that the chemical and crop company hopes will give it an edge in an emerging agricultural market.

DuPont says strong dollar to have bigger impact than expected

- Chemical maker DuPont reported lower sales in all of its businesses and said a strong dollar would take a bigger toll on its full-year earnings than it had expected.

DuPont's weak sales, forecast gives Peltz more ammo in proxy war

- DuPont's weak quarterly sales and lowered annual profit forecast provided fresh ammunition to Nelson Peltz in his campaign to win board seats and split up the chemical maker.

Select another date:
Search Stocks